Research project to develop temperature-adjustable retina laser launched

Article

A research project developing new technologies for laser treatments for the retina has been launched by the German Federal Ministry for Education and Research.

A research project developing new technologies for laser treatments for the retina has been launched by the German Federal Ministry for Education and Research. Collaboration partners on the project include Carl Zeiss Meditec, the Medical Laser Center, Lübeck, the Institute of Biomedical Optics of the University of Lübeck and the Eye Clinic of the University Hospital of Schleswig-Holstein, Germany.

The research project aims to develop a method for targeting precise doses of laser radiation to specific areas within the eye. The doses will be set automatically, to be as low as possible to reduce or eliminate side effects whilst being high enough to be optimally effective to conduct the treatment. The adjustable-temperature laser is intended to treat diseases such as diabetic retinopathy that affect a large portion of the retina.

The project was selected as the winner of the Ministry for Education and Research's "Innovation Competition for the Advancement of Medical Technology", and is anticipated to run for three years.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.